全球霍乱疫苗市场规模、份额、成长分析（按最终用户、类型）- 产业预测，2024-2031 年

Global Cholera Vaccines Market Size, Share, Growth Analysis, By End user(Hospitals, specialty clinics), By Type(Dukoral, Shanchol) - Industry Forecast 2024-2031

出版日期: 2024年03月09日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球霍乱疫苗市场规模为736.9亿美元，在预测期内（2024-2031年）从2023年的790.7亿美元增长到2031年的1389.3亿美元，预计复合年增长率为7.3% 。

引起霍乱并损害肠道的细菌感染是透过受污染的食品和水传播的。口腔、咽喉、鼻腔、眼睑的肌肉痉挛和黏膜干燥，以及严重腹泻、发烧、脱水、腹痛、心率加快、皮肤弹性下降、血压低、心率。。全球公共卫生目前受到这种感染疾病的威胁，可以透过疫苗接种来阻止这种疾病。疫苗透过将身体暴露于微量的活霍乱细菌来帮助身体增强免疫力。疫苗可以口服、静脉或肌肉内施用。疫苗是生物製药提供对某些感染疾病的免疫力并帮助发展免疫系统。包括世界卫生组织（WHO）在内的许多国际组织都使用疫苗来治疗感染疾病。霍乱是一种高度传染性疾病，由饮用被霍乱弧菌污染的饮用水或饮水所引起。潜伏期短，数小时至5天不等，特征是大量水样腹泻。霍乱有时可能致命。该疾病与卫生条件差、消毒不充分和缺乏清洁饮用水密切相关。该疾病可能呈流行病或地方病趋势。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Sanofi SA
GlaxoSmithKline plc
PaxVax Inc.（现为 Emergent BioSolutions 的一部分）
Bharat Biotech
Valneva SE
EuBiologics Co. Ltd.
Shantha Biotechnics Private Limited（赛诺菲巴斯德旗下）
Bio Farma（Indonesia Vaccine Institute）
Eubiologics Co. Ltd.
Merck & Co., Inc.
Cipla Limited
Astellas Pharma Inc.
Takeda Pharmaceutical Company Limited
Panacea Biotec Ltd.
Serum Institute of India Pvt. Ltd.
Beijing Minhai Biotechnology Co. Ltd.
Biken Corporation
OCV 联盟（比尔、梅琳达盖兹基金会、世界卫生组织等）
PaxVax Bermuda Ltd.
GSK Biologicals SA.

简介目录

Product Code: SQMIG35I2103

Global Cholera Vaccines Market size was valued at USD 73.69 billion in 2022 and is poised to grow from USD 79.07 billion in 2023 to USD 138.93 billion by 2031, growing at a CAGR of 7.3% during the forecast period (2024-2031).

The bacterial infections that cause cholera and damage the intestines are spread by contaminated food and water. Apart from cramping in the muscles and dryness of mucous membranes on the inside of the mouth, throat, nose, and eyelids, it also results in severe diarrhea, fever, dehydration, pain in the abdomen, rapid heartbeat, elasticity loss in the skin, low blood pressure, and fast heartbeat. Global public health is currently threatened by it, but immunization can halt it. By exposing the body to a tiny amount of live cholera bacteria, the vaccine helps the body acquire immunity. It can be taken orally, intravenously, or intramuscularly. A vaccination is a biological preparation that provides immunity to certain infectious diseases and aids in the development of the immune system. Vaccines are used to treat infectious diseases by a number of international organizations, including the World Health Organization (WHO). Cholera is a highly contagious disease that is caused by eating or drinking water contaminated with the vibrio cholera bacteria. The infection has a short incubation period of a few hours to five days and is characterized by abundant watery diarrhea. Cholera can occasionally prove fatal. The illness is closely linked to poor hygiene, insufficient sanitization, and a scarcity of clean drinking water. It can follow either an epidemic or an endemic trend.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cholera Vaccines Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cholera Vaccines Market Segmental Analysis

The product type, administration method, end users, distribution channel, and geographic regions are the factors that divide the worldwide market for cholera vaccines. The cholera vaccines market is divided into three categories based on type: shanchol, euvichol, and dukoral. The market is split into oral and other categories based on the method of administration. The market is divided into end-user segments based on the following: hospitals, research & academic labs, pharmaceutical & biotechnology companies, specialty clinics, and others. The cholera vaccines market has also been divided into hospital pharmacies, retail pharmacies, and other segments based on the distribution channel.

Drivers of the Global Cholera Vaccines Market

The factors predicted to drive the growth of the cholera vaccines market are the creation of novel vaccine delivery systems, raised public knowledge of cholera preventative care, and the adoption of unhealthy lifestyle practices such inadequate sanitation and the consumption of tainted food. Furthermore, the government's increased emphasis on immunization campaigns has propelled the cholera vaccine market's growth. However, the FDA's more stringent standards and drawn-out clearance procedure for novel medications could pose a challenge to the global market for cholera vaccines.

Restraints in the Global Cholera Vaccines Market

Vaccines take a long time to produce, and the need for strict regulatory approvals is projected to impede market expansion over the projection period.

Market Trends of the Global Cholera Vaccines Market

The rising incidence of cholera in the general population is the main factor driving the global market. This is a result of the inadequate hygienic and sanitation conditions in rural and isolated locations. In addition, increased public knowledge of the existence of cholera vaccinations has increased demand for the product.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Cholera Vaccines Market by End user

Market Overview
Hospitals
specialty clinics
research and academic laboratories and pharmaceutical and biotechnology companies and others

Global Cholera Vaccines Market by Type

Market Overview
Dukoral
Shanchol
Vaxchora
Euvichol
and others

Global Cholera Vaccines Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PaxVax Inc. (now part of Emergent BioSolutions)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bharat Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Valneva SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EuBiologics Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shantha Biotechnics Private Limited (part of Sanofi Pasteur)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio Farma (Indonesia Vaccine Institute)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eubiologics Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Astellas Pharma Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Panacea Biotec Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Serum Institute of India Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beijing Minhai Biotechnology Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biken Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OCV Consortium (The Bill and Melinda Gates Foundation, WHO, and others)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PaxVax Bermuda Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GSK Biologicals SA.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments